How Long Are PICC Lines Meant to Stay In?

PICCs (peripherally inserted central catheters) have no fixed expiration date. Unlike standard IVs, which typically last only a few days before they need replacing, a PICC can stay in for weeks or months, and in some cases even longer. The real determining factor is not a timer but whether the catheter is still needed and still functioning safely. Most clinical guidelines recommend daily reassessment rather than scheduled replacement, because swapping a PICC on a calendar date doesn’t reduce infection rates and exposes you to the risks of a new insertion. That said, infection and clotting risks do shift as dwell time increases, and those shifts are worth understanding.

Why There Is No Set Time Limit

You might expect a straightforward answer: remove after X weeks. But no major guideline body mandates a maximum dwell time for PICCs in adults. The CDC’s recommendations for central venous catheters in general advise against routine scheduled replacement, and PICCs follow this principle. The reasoning is practical: pulling out a working PICC and threading a new one exposes you to a fresh set of insertion-related risks, including bleeding, nerve injury, and the possibility that the new line will develop complications faster than the old one would have.

In practice, dwell times vary enormously depending on why the line was placed. Someone receiving a two-week course of IV antibiotics at home will have a PICC for roughly that long. A person undergoing several months of chemotherapy could have one in place for many weeks. One observational study of chlorhexidine-coated PICCs found a mean dwell time of about 47 days, while a trial comparing PICCs to midline catheters for outpatient antibiotic therapy reported a median of 19 days for PICCs.¹² The range reflects the treatment, not a property of the catheter itself.

When Infection Risk Starts to Rise

The biggest concern with a PICC that stays in for a long time is bloodstream infection. Bacteria can colonize the catheter surface, forming a sticky layer called a biofilm that becomes progressively harder to treat. The question researchers keep trying to pin down is: at what point does the risk meaningfully increase?

The answer depends on who you ask and which population was studied. A study analyzing adult patients found a dose-dependent relationship between catheter days and bloodstream infection risk, with an optimal statistical cutoff at about 25 days.³ A separate retrospective cohort looking at a different hospital population landed on a similar threshold of 28 days, and found that the risk climbed most steeply during the first six months.⁴ So across two independent analyses, the three-to-four-week mark appears to be where things start shifting.

But it’s not that clean-cut. A study of hematology patients, many of whom had PICCs in place for extended chemotherapy courses, found that bloodstream infection risk did not appear to increase with longer indwelling time in that specific group. The authors concluded that routine replacement of PICCs would be unlikely to prevent infections in those patients.⁵ The likely explanation is that population matters: a person’s underlying illness, immune status, how the line is maintained, and what’s being infused through it all modify the risk curve. The 25-to-28-day threshold is a useful warning flag, not a universal rule.

For PICCs that stay in much longer, the microbiology can shift. A multicenter neonatal study found that Gram-negative bloodstream infections were more than five times as common in PICCs with dwell times exceeding 50 days compared with shorter durations.⁶ Gram-negative infections tend to be harder to treat than the skin-flora organisms that dominate early infections, so both the likelihood and the severity of infection increase the longer a PICC remains in place.

Complications Beyond Infection

Infection gets the most attention, but it’s not the only reason a PICC might need to come out sooner than planned. A prospective study of hospitalized and outpatient PICC users catalogued the full range of problems:

Occlusion: About 9% of PICCs became blocked, on average around 16 days after insertion. Being older than 65 was a significant risk factor.
Accidental withdrawal: Another 9% were partially or fully dislodged, typically about 8 days in.
Infections: Just over 6% developed either a local infection or a bloodstream infection.
Venous thrombosis: About 1.6% developed a clot in the vein. Episodes occurred anywhere from 4 to 39 days after insertion.

Occlusion deserves special emphasis because it often builds gradually. More than half of pre-occlusive events in that same study occurred within the first week after insertion, and a pre-occlusive event in the week before removal was overwhelmingly the strongest predictor of full blockage.⁷ If your PICC becomes sluggish or requires extra flushing effort, that’s a sign it may not last much longer regardless of what the calendar says.

Catheter migration and dislodgement are also common enough to be a routine concern. Published estimates of the rate of catheter migration or dislodgement range from 5% to 31%, a wide spread that reflects different patient populations, securement methods, and how carefully the studies tracked small shifts in catheter position.⁸ Even a small migration can move the tip out of the correct position, which may cause the line to malfunction or irritate the vessel wall.

Blood Clots and Insertion Technique

Deep vein thrombosis in the arm is one of the more serious PICC complications. A study of orthopedic patients found that roughly 3% developed an upper-extremity clot associated with their PICC, with a prior history of DVT being a major risk factor.⁹ That number is population-specific, and the overall rate across all PICC recipients is generally lower, but the point stands: if you’ve had a blood clot before, the conversation about how long to keep a PICC should factor that history in prominently.

A systematic review and meta-analysis of PICC-related thrombosis found that the rate appears to be low when evidence-based insertion techniques are followed. Proper technique matters at the moment of insertion: using ultrasound guidance, placing the catheter in the appropriate vein, confirming tip position, and choosing the smallest catheter size that works for the intended therapy all reduce thrombosis risk.¹⁰ In other words, how the line goes in affects how safely it can stay in.

PICCs in Newborns and Infants

Neonates deserve a separate conversation because their risk profile looks different. A study of neonatal central-line infections found that all episodes of bloodstream infection occurred after a dwell time of five days, with rates increasing after nine days. The infection rate for PICCs was about 0.9 per 1,000 catheter days, which was considerably lower than for centrally inserted venous catheters in the same population but still high enough to warrant vigilant monitoring.¹¹

The multicenter neonatal cohort mentioned earlier found that infection risk increased during the first two weeks and remained elevated for the remaining life of the catheter.⁶ The authors recommended daily review of whether the PICC is still needed, emphasizing that in very small patients the threshold for removal should be lower. For neonatal PICCs, every additional day should have a clear clinical justification.

Daily Necessity Reviews

Rather than setting a removal date in advance, the standard approach is to reassess the PICC every day. This “daily necessity review” is a core part of central-line bundles used in hospitals worldwide. The question asked each day is simple: does this patient still need central venous access? If the answer is no, the line comes out. A quality-improvement study evaluating this kind of intervention found that before implementation, roughly half of patients had at least one day with a central line that had no apparent indication. After structured daily review, that proportion dropped to about a quarter.¹²

If you’re at home with a PICC, the outpatient version of this review typically happens at your weekly or biweekly dressing-change appointments with a home-health nurse. They’ll check the insertion site, flush the line, change the dressing, and assess whether the catheter is still functioning properly. Between visits, signs that something may be going wrong include redness, swelling, warmth, or tenderness at the insertion site; leaking around the catheter; difficulty flushing the line; arm swelling; or fever and chills without another explanation. Any of these warrant a call to your care team, because early intervention can sometimes save the line, while delay makes removal more likely.

When a PICC Is Not the Right Device

Part of the answer to “how long should a PICC stay in” is recognizing when a PICC should not have been chosen in the first place, or when it is time to transition to a different type of access.

For short courses of treatment, say under two weeks, a midline catheter may be a better fit. Midlines sit in the veins of the upper arm rather than reaching into the central circulation, which makes them less risky for certain complications. In a trial of outpatient antibiotic therapy, midline catheters that were in place for 14 days or fewer were associated with fewer major complications than PICCs used over the same period.² Beyond 14 days, the difference between the two devices narrowed and was no longer statistically significant. The trade-off is that midlines can’t deliver certain medications that require central venous access, so they aren’t always an option.

Midlines do come with their own downsides. A meta-analysis of randomized trials found that midline catheters had a higher rate of overall complications, were nearly four times as likely to require premature removal, and had a shorter median dwell time compared with PICCs.¹³ So while a midline may be safer in the short term for suitable therapies, it is more likely to fail before treatment is complete.

For treatment courses extending beyond about three months, a totally implanted port (sometimes called a port-a-cath) or a PICC-port is worth considering. Ports are surgically placed beneath the skin and accessed with a needle when needed, which makes them more durable and lower-maintenance between treatments. A randomized trial of nasopharyngeal carcinoma patients found that for treatment durations exceeding three months, PICC-ports were the preferred option, particularly for patients who couldn’t manage regular catheter maintenance or wanted better quality of life between infusion cycles.¹⁴

How Cost Shifts With Duration

PICCs are cheaper to insert than ports, but they require ongoing maintenance, weekly dressing changes, and flushing that add up over time. A cost-effectiveness analysis comparing PICCs with ports for chemotherapy found that PICCs were the more economical choice for treatment durations of three to nine months. However, by the nine-to-twelve-month mark, ports became more cost-effective because PICC-related complication rates climbed while port complication rates remained stable. The complication-free rate for PICCs dropped from about 65% at three to six months to roughly 44% at nine to twelve months, while ports maintained complication-free rates near 90% across all time windows.¹⁵ A broader systematic review and meta-analysis of clinical and economic outcomes likewise concluded that ports were favored for overall cost-effectiveness when longer treatment durations were anticipated.¹⁶

The practical takeaway: if your treatment plan is expected to last many months, it’s worth asking your team whether a port would serve you better than a PICC. The upfront cost and minor surgical procedure may be worthwhile given lower maintenance demands and a better complication profile over time.

Catheter Coatings and Emerging Technology

Researchers are working on ways to extend safe PICC dwell times through surface coatings that discourage bacterial colonization or clot formation. A multicenter observational study of a chlorhexidine-coated PICC reported a bloodstream infection rate of 0.82 per 1,000 catheter days, with a mean dwell time of about 47 days. Symptomatic thrombosis occurred in about 5% of patients.¹ These numbers are promising but come from a single-arm study without a direct comparison group.

Anti-thrombotic coatings are another area of interest. One study tested an anti-thrombotic surface coating and found it appeared to inhibit clot formation on the catheter surface, though it did not prevent vein inflammation (phlebitis).¹⁷ And on the infection front, laboratory research is exploring compounds like berberine that can disrupt the bacterial biofilms that form on PICC surfaces, potentially reducing the infection risk that accumulates over time.¹⁸ None of these technologies have yet changed the standard of care, but they suggest that future PICCs may tolerate longer dwell times more safely than current ones.

What Determines Your PICC’s Actual Lifespan

In practice, the duration your PICC stays in place is shaped by a handful of factors working simultaneously. The treatment course itself sets the floor: if you need four weeks of IV antibiotics, you need the line for at least four weeks. Your body’s response sets the ceiling: if a clot forms, the line occludes, or an infection develops, the PICC comes out regardless of whether treatment is finished. And your maintenance habits occupy the space between. Keeping the site dry, not tugging on the line, showing up for dressing changes, and flushing on schedule all reduce the odds of complications that force premature removal.

If your care team tells you the PICC will stay in “as long as you need it,” they are being accurate, not evasive. The honest answer is that a well-maintained, well-placed PICC in a patient without major risk factors can last several months. But every day it remains in place is a day that requires active attention, from both you and the people monitoring your care. The line does not expire on a schedule; it expires when it stops serving you safely.